Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Inventory: 2009-2024

Historic Change in Inventory for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to -$2.4 million.

  • Cumberland Pharmaceuticals' Change in Inventory fell 468.77% to -$630,409 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.8 million, marking a year-over-year decrease of 499.99%. This contributed to the annual value of -$2.4 million for FY2024, which is 10506.59% down from last year.
  • According to the latest figures from FY2024, Cumberland Pharmaceuticals' Change in Inventory is -$2.4 million, which was down 10,506.59% from $23,143 recorded in FY2023.
  • Cumberland Pharmaceuticals' Change in Inventory's 5-year high stood at $23,143 during FY2023, with a 5-year trough of -$4.8 million in FY2021.
  • Its 3-year average for Change in Inventory is -$1.1 million, with a median of -$911,078 in 2022.
  • Its Change in Inventory has fluctuated over the past 5 years, first surged by 102.54% in 2023, then tumbled by 10,506.59% in 2024.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Change in Inventory stood at -$2.1 million in 2020, then slumped by 125.98% to -$4.8 million in 2021, then soared by 81.08% to -$911,078 in 2022, then skyrocketed by 102.54% to $23,143 in 2023, then plummeted by 10,506.59% to -$2.4 million in 2024.